Loading…
Drug Conjugation to Cyclic Peptide-Polymer Self-Assembling Nanotubes
We show for the first time how polymeric nanotubes (NTs) based on self‐assembled conjugates of polymers and cyclic peptides can be used as an efficient drug carrier. RAPTA‐C, a ruthenium‐based anticancer drug, was conjugated to a statistical co‐polymer based on poly(2‐hydroxyethyl acrylate) (pHEA) a...
Saved in:
Published in: | Chemistry : a European journal 2014-09, Vol.20 (40), p.12745-12749 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | We show for the first time how polymeric nanotubes (NTs) based on self‐assembled conjugates of polymers and cyclic peptides can be used as an efficient drug carrier. RAPTA‐C, a ruthenium‐based anticancer drug, was conjugated to a statistical co‐polymer based on poly(2‐hydroxyethyl acrylate) (pHEA) and poly(2‐chloroethyl methacrylate) (pCEMA), which formed the shell of the NTs. Self‐assembly into nanotubes (length 200–500 nm) led to structures exhibiting high activity against cancer cells.
Polymeric nanotubes (NTs) based on self‐assembled conjugates of polymers and cyclic peptides can be used as an efficient drug carrier for RAPTA‐C, a ruthenium‐based anticancer drug. The drug was conjugated to a water‐soluble polymer, which formed the shell of the NTs. The self‐assembled nanotubes (ca. 200–500 nm in length) had a significant activity against cancer cells (see figure). |
---|---|
ISSN: | 0947-6539 1521-3765 |
DOI: | 10.1002/chem.201403130 |